***********APPLY NOW by submitting the application form***********
Link to the application form (Deadline: 30 April 2026)
On-site course in pharmaceutical pricing and reimbursement policies
The WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, based at the Pharmacoeconomics Department of the Austrian National Public Health Institute, is pleased to offer an in-person Summer School on pharmaceutical and reimbursement policies in Vienna from 25 – 28 August 2026. Led by international experts, the Vienna Summer School provides four days of intensive training, interaction, and insights into pharmaceutical pricing and reimbursement policies and solutions to address current challeng-es.
The School offers a tailored programme to a global audience of policymakers and technical experts working on the pricing and reimbursement of medicines in public authorities including payers in health care systems. Participants will meet on-site in Vienna for four days and enjoy a unique mix of learning, knowledge exchange, interaction, practice-based discus-sions, and networking. Due to the range of topics that the Summer School covers, it is suitable for experts in public authorities who have only recently started working on questions of pharmaceutical pricing and reimbursement, as well as more experienced colleagues who would like to engage in in-depth discussions and exchanges on current policy challenges and potential solutions.
The Summer School will cover a breadth of topics including:
- Pricing and policies along the pharmaceutical value chain
- Sources of price data and the use of such data in pricing decisions
- The politics and ethics of prioritising medicines for funding in public health care sys-tems
- Reimbursement policy options and coverage decisions
- Managed-entry agreements and price negotiations
- A menu of policy solutions to tackle the challenges in pharmaceutical policy (e.g. access to high-priced medicines; geopolitical developments)
- Public communication of policies and decisions
Depending on the mix of applicants from high-, middle- and lower-income countries, we will tailor the programme to meet the needs of the participants.
Learning objectives
- To gain insight into current policy debates and evidence-based knowledge in pharma-ceutical pricing and reimbursement.
- To understand the concepts, strategies, and effects of pharmaceutical pricing and reimbursement.
- To engage with the complexities of priority-setting in pharmaceutical policy, and communicating relevant decisions to patients and the public.
- To gain an overview of the available tools to adapt policies to current and future challenges.
- To learn from the experiences of other countries.